Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrocortisone | 11 | 2018 | 188 | 1.750 |
Why?
|
| Hypothalamo-Hypophyseal System | 8 | 2016 | 88 | 1.590 |
Why?
|
| Pituitary-Adrenal System | 6 | 2016 | 60 | 0.890 |
Why?
|
| Spouses | 4 | 2018 | 38 | 0.770 |
Why?
|
| Object Attachment | 4 | 2013 | 20 | 0.760 |
Why?
|
| Marriage | 3 | 2016 | 25 | 0.730 |
Why?
|
| Gender Identity | 1 | 2020 | 61 | 0.690 |
Why?
|
| Stress, Psychological | 6 | 2017 | 451 | 0.680 |
Why?
|
| Interpersonal Relations | 8 | 2020 | 151 | 0.680 |
Why?
|
| Transgender Persons | 1 | 2020 | 63 | 0.670 |
Why?
|
| Depression | 5 | 2018 | 868 | 0.600 |
Why?
|
| Mental Health | 1 | 2020 | 350 | 0.570 |
Why?
|
| Biomarkers | 1 | 2020 | 1213 | 0.500 |
Why?
|
| Adaptation, Psychological | 3 | 2007 | 264 | 0.470 |
Why?
|
| Anxiety | 2 | 2016 | 400 | 0.430 |
Why?
|
| Saliva | 8 | 2016 | 96 | 0.380 |
Why?
|
| Family Characteristics | 2 | 2020 | 44 | 0.330 |
Why?
|
| Temperament | 1 | 2007 | 18 | 0.280 |
Why?
|
| Arousal | 1 | 2007 | 42 | 0.280 |
Why?
|
| Adolescent | 11 | 2018 | 5958 | 0.260 |
Why?
|
| Courtship | 1 | 2006 | 5 | 0.260 |
Why?
|
| Family Conflict | 2 | 2018 | 6 | 0.260 |
Why?
|
| Negotiating | 1 | 2006 | 16 | 0.260 |
Why?
|
| Premature Birth | 2 | 2017 | 108 | 0.250 |
Why?
|
| Female | 21 | 2020 | 31250 | 0.250 |
Why?
|
| Emotions | 1 | 2007 | 218 | 0.240 |
Why?
|
| Sex Characteristics | 4 | 2016 | 197 | 0.220 |
Why?
|
| Male | 14 | 2020 | 27971 | 0.220 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 243 | 0.220 |
Why?
|
| Self-Injurious Behavior | 1 | 2003 | 47 | 0.210 |
Why?
|
| Adult | 13 | 2018 | 15985 | 0.200 |
Why?
|
| Vitamin D | 2 | 2014 | 149 | 0.190 |
Why?
|
| Sex Factors | 3 | 2016 | 969 | 0.180 |
Why?
|
| Young Adult | 9 | 2018 | 4396 | 0.180 |
Why?
|
| Humans | 21 | 2020 | 60132 | 0.170 |
Why?
|
| Machine Learning | 1 | 2020 | 150 | 0.160 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2018 | 9 | 0.150 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2016 | 13 | 0.130 |
Why?
|
| Family Relations | 1 | 2016 | 22 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 189 | 0.130 |
Why?
|
| Pregnant Women | 1 | 2017 | 91 | 0.130 |
Why?
|
| Pregnancy | 3 | 2018 | 2367 | 0.130 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1237 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2018 | 387 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 190 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 260 | 0.110 |
Why?
|
| Social Perception | 1 | 2013 | 36 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2018 | 2616 | 0.110 |
Why?
|
| Antidepressive Agents | 2 | 2012 | 229 | 0.110 |
Why?
|
| alpha-Amylases | 1 | 2013 | 6 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2016 | 292 | 0.110 |
Why?
|
| Premenstrual Syndrome | 1 | 2014 | 96 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 371 | 0.100 |
Why?
|
| Calcium | 2 | 2014 | 558 | 0.100 |
Why?
|
| Salivary alpha-Amylases | 1 | 2012 | 2 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 392 | 0.100 |
Why?
|
| Cholecalciferol | 1 | 2012 | 27 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2013 | 185 | 0.100 |
Why?
|
| Prospective Studies | 5 | 2018 | 3131 | 0.100 |
Why?
|
| Vitamins | 1 | 2012 | 82 | 0.090 |
Why?
|
| Exercise | 1 | 2018 | 918 | 0.090 |
Why?
|
| Models, Psychological | 2 | 2013 | 93 | 0.090 |
Why?
|
| Attention | 1 | 2012 | 151 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2011 | 249 | 0.080 |
Why?
|
| Cognition | 1 | 2012 | 466 | 0.070 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2017 | 27 | 0.070 |
Why?
|
| Individuality | 1 | 2007 | 21 | 0.070 |
Why?
|
| Diet | 1 | 2011 | 637 | 0.070 |
Why?
|
| Massachusetts | 2 | 2018 | 2118 | 0.070 |
Why?
|
| Puerto Rico | 2 | 2017 | 233 | 0.070 |
Why?
|
| Affect | 1 | 2006 | 124 | 0.060 |
Why?
|
| Linear Models | 1 | 2006 | 422 | 0.060 |
Why?
|
| Self Report | 2 | 2020 | 369 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 928 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2017 | 1315 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2014 | 774 | 0.050 |
Why?
|
| Middle Aged | 5 | 2016 | 16535 | 0.040 |
Why?
|
| Logistic Models | 2 | 2014 | 1259 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2003 | 374 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2362 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 13 | 0.040 |
Why?
|
| United States | 3 | 2017 | 7622 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 58 | 0.040 |
Why?
|
| Dominican Republic | 1 | 2017 | 23 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2017 | 25 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 29 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 37 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 39 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2017 | 180 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 43 | 0.030 |
Why?
|
| Helping Behavior | 1 | 2013 | 5 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 197 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 281 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 309 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1066 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 50 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 435 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 377 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 680 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 1937 | 0.020 |
Why?
|
| Postmenopause | 1 | 2011 | 246 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2479 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1002 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1300 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 13581 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2505 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 5082 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5262 | 0.010 |
Why?
|